Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000434028 | SCV000534561 | likely pathogenic | not provided | 2017-01-03 | criteria provided, single submitter | clinical testing | The Y2282C variant in the NIPBL gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. The Y2282C variant was not observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The Y2282C variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. Therefore, the Y2282C variant is a strong candidate for a pathogenic variant |